No abstract available
MeSH terms
-
Acitretin / adverse effects
-
Acitretin / therapeutic use
-
Adalimumab
-
Adult
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Cyclosporine / adverse effects
-
Cyclosporine / therapeutic use
-
Dermatologic Agents / therapeutic use
-
Etanercept
-
Humans
-
Immunoglobulin G / adverse effects
-
Immunoglobulin G / therapeutic use
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Infliximab
-
Male
-
Melanoma / diagnosis*
-
Melanoma / etiology*
-
Melanoma / pathology
-
Methotrexate / therapeutic use
-
Psoriasis / drug therapy
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Severity of Illness Index
-
Skin Neoplasms / diagnosis*
-
Skin Neoplasms / etiology*
-
Skin Neoplasms / pathology
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
Immunoglobulin G
-
Immunosuppressive Agents
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Cyclosporine
-
Infliximab
-
Adalimumab
-
Acitretin
-
Etanercept
-
Methotrexate